Genetic study of a trisomy 13 fetus with a false-negative karyotype by chorionic villi analysis.
10.3760/cma.j.issn.1003-9406.2020.08.008
- Author:
Shanshan SHI
1
;
Qingbing ZHA
;
Zijian SHI
;
Ruiman LI
Author Information
1. Department of Fetal Medicine, the First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510630, China. hqyylrm@126.com.
- Publication Type:Journal Article
- From:
Chinese Journal of Medical Genetics
2020;37(8):839-842
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the mechanism of a false-negative result from karyotyping of chorionic villi cells for a trisomy 13 fetus featuring multiple malformations.
METHODS:For a fetus with multiple malformations by ultrasonography and a 46,XY karyotype by chorionic villi analysis, amniocytes were further analyzed with quantitative fluorescence PCR (QF-PCR), G-banded karyotyping and chromosomal microarray analysis (CMA). Meanwhile, non-invasive prenatal testing (NIPT) was conducted on peripheral blood sample from the pregnant woman to determine the chromosomal composition of cytotrophoblast. After induction of labor, common aneuploidies in placenta and fetal tissue were also analyzed by QF-PCR.
RESULTS:QF-PCR, chromosomal karyotyping and CMA analysis of the amniocytes all suggested complete trisomy 13 (47,XY,+13) in the fetus. NIPT also suggested existence of fetal trisomy 13. QF-PCR analysis of the placenta and fetal tissues revealed that cells derived from the maternal surface and right side of fetal surface harbored mosaic trisomy 13, while those derived from other sites of fetal surface of the placenta, umbilical cord, amniotic membrane and fetal muscle tissue harbored trisomy 13.
CONCLUSION:Karyotyping of long-term cultured chorionic villus sample may give rise to false negative results due to placental mosaicism. To ensure accurate prenatal diagnosis, discordance between karyotyping of chorionic villi cells, fetal ultrasound and NIPT result should be verified by amniocentesis or cordocentesis and application of multiple cytogenetic and molecular techniques.
